Apitope's Series B Round

Apitope raised a round of funding on September 29, 2015.

Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves' …

Articles about Apitope's Series B Round: